Zhaoyang Zhong

First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study

Yi‐Long Wu, Caicun Zhou, Chong Kin Liam et al. · Annals of Oncology · 2015 · 726 citations

Medicine, Phase Iii, Pathology +7

Nanogold-enwrapped graphene nanocomposites as trace labels for sensitivity enhancement of electrochemical immunosensors in clinical immunoassays: Carcinoembryonic antigen as a model

Zhaoyang Zhong, Wei Wu, Dong Wang et al. · Biosensors and Bioelectronics · 2010 · 205 citations

Engineering, Biosensing Systems, Nanomaterials +9

APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells

Dong Wang, Debing Xiang, Xueqin Yang et al. · Lung Cancer · 2009 · 190 citations

Cisplatin Resistance, Oncology, Targeted Inhibition +11

Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the β-catenin/T-cell factor signaling

Debing Xiang, Dong Wang, Yujun He et al. · Anti-Cancer Drugs · 2006 · 118 citations

Identification and Characterization of Mitochondrial Targeting Sequence of Human Apurinic/Apyrimidinic Endonuclease 1

Mengxia Li, Zhaoyang Zhong, Jianwu Zhu et al. · Journal of Biological Chemistry · 2010 · 95 citations · Full text